These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 6814755

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Biochemical basis for using selective monoamine oxidase inhibitors in the treatment of Parkinson's disease. Critical contribution].
    Amato L, Nava L, Rizzo M, Piccoli F.
    Riv Neurol; 1985; 55(1):46-52. PubMed ID: 3927468
    [No Abstract] [Full Text] [Related]

  • 3. Deprenyl (selegiline) in the treatment of Parkinson's disease.
    Birkmayer W.
    Acta Neurol Scand Suppl; 1983; 95():103-5. PubMed ID: 6428140
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. L-deprenyl in the treatment of Parkinson's disease.
    Csanda E, Tárczy M, Takáts A, Mogyorós I, Köves A, Katona G.
    J Neural Transm Suppl; 1983; 19():283-90. PubMed ID: 6421993
    [Abstract] [Full Text] [Related]

  • 7. (-)-Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's disease.
    Birkmayer W, Knoll J, Riederer P, Youdim MB.
    Mod Probl Pharmacopsychiatry; 1983; 19():170-6. PubMed ID: 6408405
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Deprenyl in Parkinson's disease.
    Lancet; 1982 Sep 25; 2(8300):695-6. PubMed ID: 6126632
    [No Abstract] [Full Text] [Related]

  • 10. Monoamine oxidase activity during (--)-deprenil therapy: human brain post-mortem studies.
    Riederer P, Youdim MB, Birkmayer W, Jellinger K.
    Adv Biochem Psychopharmacol; 1978 Sep 25; 19():377-82. PubMed ID: 696465
    [No Abstract] [Full Text] [Related]

  • 11. Deprenyl and levodopa and Parkinson's disease progression.
    Fowler JS, Fazzini E, Volkow ND.
    Ann Neurol; 1996 Aug 25; 40(2):267-8. PubMed ID: 8773616
    [No Abstract] [Full Text] [Related]

  • 12. Deprenyl is a selective inhibitor of brain MAO-B in the long-term treatment of Parkinsons's disease.
    Reiderer P, Reynolds GP.
    Br J Clin Pharmacol; 1980 Jan 25; 9(1):98-9. PubMed ID: 6766730
    [No Abstract] [Full Text] [Related]

  • 13. Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl.
    Riederer P, Youdim MB.
    J Neurochem; 1986 May 25; 46(5):1359-65. PubMed ID: 2420928
    [Abstract] [Full Text] [Related]

  • 14. Selegiline in the treatment of Parkinson's disease.
    Heinonen EH, Rinne UK.
    Acta Neurol Scand Suppl; 1989 May 25; 126():103-11. PubMed ID: 2515715
    [Abstract] [Full Text] [Related]

  • 15. Deprenyl (selegiline) in the treatment of Parkinson's disease.
    Rinne UK.
    Acta Neurol Scand Suppl; 1983 May 25; 95():107-11. PubMed ID: 6428141
    [Abstract] [Full Text] [Related]

  • 16. Clinical evaluation of deprenyl (selegiline) in the treatment of Parkinson's disease.
    Csanda E, Tárczy M.
    Acta Neurol Scand Suppl; 1983 May 25; 95():117-22. PubMed ID: 6428143
    [Abstract] [Full Text] [Related]

  • 17. R-(-)-deprenyl and parkinsonism.
    Yahr MD.
    J Neural Transm Suppl; 1987 May 25; 25():5-12. PubMed ID: 3123605
    [Abstract] [Full Text] [Related]

  • 18. Deprenyl (selegiline) in combination treatment of Parkinson's disease.
    Gerstenbrand F, Ransmayr G, Poewe W.
    Acta Neurol Scand Suppl; 1983 May 25; 95():123-6. PubMed ID: 6428144
    [Abstract] [Full Text] [Related]

  • 19. Deprenyl in the treatment of Parkinson's disease. A specific type B monoamine oxidase inhibitor.
    Lieberman AN, Gopinathan G, Neophytides A, Hiesiger E, Nelson J, Walker R, Goodgold A.
    N Y State J Med; 1984 Jan 25; 84(1):13-6. PubMed ID: 6422358
    [No Abstract] [Full Text] [Related]

  • 20. Long-term effects of L-deprenyl in chronic levodopa treated parkinsonian patients.
    Streifler M, Rabey MJ.
    J Neural Transm Suppl; 1983 Jan 25; 19():265-72. PubMed ID: 6421992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.